Baidu slides about 5% as prior chip-IPO optimism fades and traders de-risk ahead of earnings

Baidu, Inc. (BIDU) is down 5.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop looks driven by a reversal of recent optimism around Baidu’s AI-chip subsidiary listing plans, with traders taking profits after a sharp run-up. The move also appears consistent with risk-off positioning in U.S.-listed China tech ahead of Baidu’s next earnings report.

Details:

Baidu’s AI chip unit Kunlunxin has been linked to a potential dual-listing path (including Shanghai and Hong Kong), which helped fuel a recent rally and raised expectations for value-unlock; today’s decline may reflect profit-taking after that surge.

Baidu has already disclosed that the proposed Kunlunxin spin-off/listing is not assured, which can increase volatility as investors reprice the probability and timing of the transaction.

Baidu is scheduled to report first-quarter 2026 financial results on May 18, 2026, and some investors often reduce exposure into results when near-term expectations have moved higher.

This could also be amplified by broader weakness in large-cap Chinese internet names after a major peer’s latest results highlighted margin pressure from elevated AI and infrastructure spending.

Sources:

Baidu Investor Relations, Bloomberg, Alibaba Group press release, Market data

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BIDU Hedge Fund Activity

We have seen 266 institutional investors add shares of $BIDU stock to their portfolio, and 256 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DODGE & COX removed 4,387,885 shares (-99.6%) from their portfolio in Q4 2025, for an estimated $573,321,054
BLACKROCK, INC. added 2,042,847 shares (+805.4%) to their portfolio in Q1 2026, for an estimated $221,853,184
HHLR ADVISORS, LTD. removed 1,641,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $214,413,060
MACQUARIE GROUP LTD removed 1,032,502 shares (-99.6%) from their portfolio in Q4 2025, for an estimated $134,906,711
PRIMECAP MANAGEMENT CO/CA/ removed 1,008,700 shares (-8.3%) from their portfolio in Q4 2025, for an estimated $131,796,742
ORBIS ALLAN GRAY LTD removed 789,432 shares (-75.6%) from their portfolio in Q4 2025, for an estimated $103,147,185
CITADEL ADVISORS LLC added 758,787 shares (+409.0%) to their portfolio in Q4 2025, for an estimated $99,143,109

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$BIDU Analyst Ratings

Wall Street analysts have issued reports on $BIDU in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Overweight" rating on 11/24/2025
Goldman Sachs issued a "Buy" rating on 11/19/2025
Benchmark issued a "Buy" rating on 11/19/2025
B of A Securities issued a "Buy" rating on 11/19/2025

To track analyst ratings and price targets for $BIDU, check out Quiver Quantitative's $BIDU forecast page.

$BIDU Price Targets

Multiple analysts have issued price targets for $BIDU recently. We have seen 9 analysts offer price targets for $BIDU in the last 6 months, with a median target of $155.0.

Here are some recent targets:

Jiong Shao from Barclays set a target price of $128.0 on 03/06/2026
Shyam Patil from Susquehanna set a target price of $120.0 on 03/05/2026
Roman Lukianchikov from Freedom Capital Markets set a target price of $160.0 on 01/07/2026
Thomas Chong from Jefferies set a target price of $181.0 on 01/02/2026
Alex Yao from JP Morgan set a target price of $188.0 on 11/24/2025
Lincoln Kong from Goldman Sachs set a target price of $155.0 on 11/19/2025
Fawne Jiang from Benchmark set a target price of $158.0 on 11/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.